## 

## 

## 

|||||||Page|
|---|---|---|---|---|---|---|
|Trustees'<br>annual<br>report (incorporating|||the|director's|report)||
|Independent<br>examiner's<br>report||to the|trustees||||
|Statement<br>offinancial|activities|(including||income and|||
|expenditure<br>account)|||||||
|Statement<br>offinancial|position||||||
|Notes to the financial|statements||||||





# 

## 

## 

## 

## 

|Registered||charity|name|name|Arab Scientific Community|Arab Scientific Community|Arab Scientific Community|Organisation|
|---|---|---|---|---|---|---|---|---|
|Charity registration|||number||1134734||||
|Company|registration|||number|07030880||||
|Principal office and|||registered||7 Redbridge|Lane East|||
|office|||||liford||||
||||||Essex IG4|5ET|||
|The trustees|||||||||
||||||Dr M Al-Rabban||||
||||||Al Rabban|Foundation|for|Studies|
||||||&Research||||
|Company|secretary||||Dr M Al-Rabban||||
|Independent||examiner|||R C Patel, FCA FCCA||||
||||||7 Redbridge|Lane East|||
||||||Redbridge,|llford|||
||||||Essex IG4 5ET||||



## 

## 



## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|||||2020|2020|2019|
|---|---|---|---|---|---|---|
|||||Unrestricted|||
|||||funds|Total funds|Total funds|
||||Note|$|$|$|
|Income and endowments|||||||
|Donations<br>and|legacies||5|199,805|199,805|158,022|
|Total income||||199,805|199,805|158,022|
|Expenditure|||||||
|Expenditure<br>on|charitable|activities|6,7|194,741|194,741|173,917|
|Total expenditure||||194,741|194,741|173,917|
|Net income/(expenditure)||and net movement|in funds|5,064|5,064|(15,895)|
|Reconciliation|offunds||||||
|Total funds brought<br>forward||||5,580|5,580|21,475|
|Total funds carried forward||||10,644|10,644|5,580|





## 

## 

## 

## 

||||2020||2019|
|---|---|---|---|---|---|
|||Note|$|||
|Current assets||||||
|Debtors||12|12,030||6,630|
|Creditors: amounts|falling due within one year|13|1,386||1,050|
|Net current assets||||10,644|5,580|
|Total assets less current liabilities||||10,644|5,580|
|Net assets||||10,644|5,580|
|Funds ofthe charity<br>Unrestricted<br>funds||||10,644|5,580|
|Total charity funds||||10,644|5,580|





# 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|Donations||and legacies||Unrestricted<br>Total Funds<br>Funds<br>2020<br>$:$|Unrestricted<br>Total Funds<br>Funds<br>2020<br>$:$|Unrestricted<br>Funds<br>-<br>-<br>$|Unrestricted<br>Funds<br>-<br>-<br>$|Total Funds<br>2019<br>.<br>$|Total Funds<br>2019<br>.<br>$|
|---|---|---|---|---|---|---|---|---|---|
|Donations<br>Donations|and contributions|||199,805|199,805|-|158,022|- "|.158;022|
|Expenditure||on charitable|activities|by fund type||||||
|||||Unrestricted|Total Funds|Unrestricted||Total Funds||
|||||Funds|2020||Funds|'|2019|
|||||$|$||$|'|$|
|Research<br>Support costs||||193,250<br>1,491|193,250<br>1,491||172,810<br>.<br>1;107|.<br>'|172,810<br> ' 1,107|
|||||194,741|194,741'||'l73,917||"173;917|



## 

## 

## 

|Expenditure|on charitable<br>ac|tivities<br>by activity typ|e||||
|---|---|---|---|---|---|---|
|||Activities|||||
|||undertaken|||Tdtal funds|Total fund|
|||directly|Support|costs|2020|2019|
|Research||$ 193,250||$|$ 193,250|$ 172,810|
|Governance|costs|||1,491|1,491|1,107|
|||193,250||1,491|194,741|173',917|



## 

|8.|Analysis of|support cost|s|||||||
|---|---|---|---|---|---|---|---|---|---|
||||||Analysis<br>of|||||
||||||support costs<br>activity1<br>$.<br>.|Total 2020,<br>$||Total 2019<br>$. . .||
||Governance|costs|||1,491|1,491|.|—|1.,107|
|9.|Independent|examination|fees|||||||
|||||||2020|||'201'9|
|||||||$|||$|
||Fees payable <br>Independent|to the independent<br>examination<br>ofthe||examiner for:<br> financial statements||2,598|||1,'1 07|





## 

## 

## 

## 

## 

## 

## 

|12.|received by t<br>Debtors|he truste|es.|||
|---|---|---|---|---|---|
|||||, ".2020|2019|
|||||$|$|
||Prepayments|and accrued income||12,030|6,630|
|13.|Creditors: amounts||falling due within one year|||
|||||2020|2019|
|||||$|$|
||Accruals and|deferred|income|1,386|1,050|





## 

## 

## 

## 

## 

|Unrestricted<br>funds||||||
|---|---|---|---|---|---|
||||||At|
|||At|||31 December|
|||1 January 2020|Income|Expenditure|2020|
|||$|$|$|$|
|General funds||5,580|199,805|(194,741)|10,644|
||||||At|
|||At||31 December 2||
|||1 January 2019|Income|Expenditure|019|
|||$|$|$|$|
|General funds||21,475|158,022|(173,917)|5,580|
|Analysis ofnet assets between funds||||||
|||||Unrestricted|Total Funds|
|||||Funds|2020|
|||||$|$|
|Current assets||||12,030|12,030|
|Creditors less than|1 year|||(1,386)|(1,386)|
|Net assets||||10,644|10,644|
|||||Unrestricted|Total Funds|
|||||Funds|2019|
|||||$|$|
|Current assets||||6,630|6,630|
|Creditors less than|1 year|||(1,050)|(1,050)|
|Net assets||||5,580|5,580|



## 

##